Blockchain Registration Transaction Record
GeoVax to Host Conference Call to Discuss 2024 Financial Results and Corporate Update
GeoVax Labs, Inc. will report 2024 financial results and host a conference call to discuss corporate updates. Learn about the clinical-stage biotechnology company's focus on developing vaccines and therapies for cancer and infectious diseases.

This news matters as it provides investors and stakeholders with an opportunity to learn about GeoVax's financial performance and corporate developments. It also highlights the company's focus on developing innovative vaccines and therapies for infectious diseases and solid tumor cancers, showcasing its commitment to advancing healthcare solutions.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x782e6c1b97ef09657dac17e782d73e19bb6f19132fa875460f14f7cdbbf8c4df |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | bakeC3GB-070c1985ef6747b349074d89a9ea7389 |